Azopharma Gains MHRA GMP Approval

Azopharma Drug Development Services has received approval from the Medicines and Healthcare products Regulatory Agency (MHRA) for production of commercial product. A Good Manufacturing Practice (GMP) certificate was issued following the successful audit of the company’s Hollywood facilities conducted in December 2009. The facilities, equipment and quality systems were found to be compliant with GMP guidelines.

Melissa Porazzo, vice president of corporate compliance said, “This is an exciting accomplishment for us. Our quality assurance and regulatory teams work diligently to maintain high quality standards and this certificate is evidence of the improvement of our quality systems.”

Click here for more information about Azopharma